NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

The problem with discussing price and how BP affects the ultimate value that the company is sold is twofold. First, the stock is traded OTC which places a drag or limit on the stock price - I’ve mentioned many times that it’s nearly impossible to find any stock traded exclusively as an OTC that has a $ billion plus market cap.

The second issue is BP is not monolith. It‘s unlikely that Big Pharma is in some form of anti-trust collusion with one another to suppress the stock price and undermine the company. LP already did that herself by delisting the stock. And a low stock price with only one or two potential buyers will mean low ball bids. Moreover, the low stock price also invites modest unwanted tender offers.

Now, in order to overcome the low stock price, either there has to be a bidding war between multiple players for an outright acquisition or the company has to enter into a joint venture or partnering arrangement with whoever is available. Then followed by an uplisting of the stock in order to let institutional market forces to take hold and raise the price. That might be the plan with Merck, to gain some capital and then uplist, which will place the company in a better position to sell.